The Community Guide

- gsearch

Search Results

Narrow Results:

2022 2
2021 1
2020 1
2019 1
2017 1
1998 1
1989 2
1979 1
1967 1

Health Evaluation and Technical Assistance (HETA) 1

National Institute for Occupational Safety and Health 4

Journal Article 6
Text 5

1 - 11 of 11 Results

Refine Results

Refine Results:

Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir

CITE Title : Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir Personal Author(s) : Chesnokov, Anton;Patel, Mira C.;Mishin, Vasiliy P.;De La Cruz, Juan A.;Lollis, Lori;Nguyen, Ha T.;Dugan, Vivien;Wentworth, David E.;Gubareva, Larisa V.; Published Date : 1 14 2020;1-14-; Source : J Infect Dis. 221(3):367-371 URL : https://stacks.cdc.gov/view/cdc/114582 Chesnokov, Anton et al. (2020). Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir. 221(3). Chesnokov, Anton et al. "Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir" 221, no. 3 (2020) Chesnokov, Anton et al. "Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir" vol. 221, no. 3, 2020 Export RIS Citation Information.

:

Chesnokov, Anton ;

Patel, Mira C.

1 14 2020 | J Infect Dis. 221(3):367-371

:

Susceptibility of influenza A viruses to baloxavir can be affected by changes at amino acid residue 38 in the polymerase acidic (PA) protein. Informat...
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

CITE Title : Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020 Personal Author(s) : Govorkova, Elena A.;Takashita, Emi;Daniels, Rod S.;Fujisaki, Seiichiro;Presser, Lance D.;Patel, Mira C.;Huang, Weijuan;Lackenby, Angie;Nguyen, Ha T.;Pereyaslov, Dmitriy;Rattigan, Aine;Brown, Sook Kwan;Samaan, Magdi;Subbarao, Kanta;Wong, Sun;Wang, Dayan;Webby, Richard J.;Yen, Hui-Ling;Zhang, Wenqing;Meijer, Adam;Gubareva, Larisa V.; Published Date : 4 2022 Source : Antiviral Res. 200:105281 URL : https://stacks.cdc.gov/view/cdc/119349 Govorkova, Elena A. et al. (2022). Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020. 200 Govorkova, Elena A. et al. "Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020" 200 (2022) Govorkova, Elena A. et al. "Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020" vol. 200, 2022 Export RIS Citation Information.

:

Govorkova, Elena A. ;

Takashita, Emi

4 2022 | Antiviral Res. 200:105281

:

Global analysis of the susceptibility of influenza viruses to neuraminidase (NA) inhibitors (NAIs) and the polymerase acidic (PA) inhibitor (PAI) balo...
Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir

CITE Title : Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir Personal Author(s) : Mishin, Vasiliy P.;Patel, Mira C.;Chesnokov, Anton;De La Cruz, Juan;Nguyen, Ha T.;Lollis, Lori;Hodges, Erin;Jang, Yunho;Barnes, John;Uyeki, Timothy;Davis, Charles T.;Wentworth, David E.;Gubareva, Larisa V.; Published Date : October 17 2019 Source : Emerg Infect Dis. 25(10):1969-1972 URL : https://stacks.cdc.gov/view/cdc/82964 Mishin, Vasiliy P. et al. (2019). Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir. 25(10). Mishin, Vasiliy P. et al. "Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir" 25, no. 10 (2019) Mishin, Vasiliy P. et al. "Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir" vol. 25, no. 10, 2019 Export RIS Citation Information.

:

Mishin, Vasiliy P. ;

Patel, Mira C.

October 17 2019 | Emerg Infect Dis. 25(10):1969-1972

:

Baloxavir showed broad-spectrum in vitro replication inhibition of 4 types of influenza viruses (90% effective concentration range 1.2-98.3 nmol/L); s...
Tests Of 15 Experimental Molluscicides Against Australorbis Glabratus

CITE Title : Tests Of 15 Experimental Molluscicides Against Australorbis Glabratus Personal Author(s) : Seiffer, Eric A.;Schoof, Herbert F.; Published Date : 09/01/1967 Source : Public Health Rep. 82(9):833-839 URL : https://stacks.cdc.gov/view/cdc/74798 Seiffer, Eric A. and Schoof, Herbert F. (1967). Tests Of 15 Experimental Molluscicides Against Australorbis Glabratus. 82(9). Seiffer, Eric A. and Schoof, Herbert F. "Tests Of 15 Experimental Molluscicides Against Australorbis Glabratus" 82, no. 9 (1967) Seiffer, Eric A. and Schoof, Herbert F. "Tests Of 15 Experimental Molluscicides Against Australorbis Glabratus" vol. 82, no. 9, 1967 Export RIS Citation Information.

:

Seiffer, Eric A. ;

Schoof, Herbert F.

09/01/1967 | Public Health Rep. 82(9):833-839

No Description
The Impact of a PDMP-EHR Data Integration combined with Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area

CITE Title : The Impact of a PDMP-EHR Data Integration combined with Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area Personal Author(s) : Calcaterra, Susan L.;Butler, Maria;Olson, Katie;Blum, Joshua; Published Date : 2022;May-Jun 2022; Source : J Addict Med. 16(3):324-332 URL : https://stacks.cdc.gov/view/cdc/114379 Calcaterra, Susan L. et al. (2022). The Impact of a PDMP-EHR Data Integration combined with Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area. 16(3). Calcaterra, Susan L. et al. "The Impact of a PDMP-EHR Data Integration combined with Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area" 16, no. 3 (2022) Calcaterra, Susan L. et al. "The Impact of a PDMP-EHR Data Integration combined with Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area" vol. 16, no. 3, 2022 Export RIS Citation Information.

:

Calcaterra, Susan L. ;

Butler, Maria

2022 | J Addict Med. 16(3):324-332

:

IntroductionDespite inconclusive evidence that prescription drug monitoring programs (PDMP) reduce opioid-related mortality, guidelines recommend PDMP...
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group

CITE Title : Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group Personal Author(s) : Ison, Michael G.;Hayden, Frederick G.;Hay, Alan J.;Gubareva, Larisa V.;Govorkova, Elena A.;Takashita, Emi;McKimm-Breschkin, Jennifer L.; Published Date : 10 2021;10-2021; Source : Antiviral Res. 194:105158 URL : https://stacks.cdc.gov/view/cdc/116479 Ison, Michael G. et al. (2021). Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group. 194 Ison, Michael G. et al. "Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group" 194 (2021) Ison, Michael G. et al. "Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group" vol. 194, 2021 Export RIS Citation Information.

:

Ison, Michael G. ;

Hayden, Frederick G.

10 2021 | Antiviral Res. 194:105158

:

It is more than 20 years since the neuraminidase inhibitors, oseltamivir and zanamivir were approved for the treatment and prevention of influenza. Gu...
Health Hazard Evaluation Report: HETA 91–0047–2672: Golden Valley Electric Association, Healy, Alaska

CITE Title : Health Hazard Evaluation Report: HETA 91–0047–2672: Golden Valley Electric Association, Healy, Alaska Personal Author(s) : Burkhart, Joseph E.;Filios, Margaret S.; Corporate Authors(s) : National Institute for Occupational Safety and Health Published Date : 1998/02/01 Pages in Document : 60 pdf pages Series : Health Hazard Evaluation Reports (HHE) DOI : https://doi.org/10.26616/NIOSHHETA9100472672 Burkhart, Joseph E. and Filios, Margaret S. (1998). Health Hazard Evaluation Report: HETA 91–0047–2672: Golden Valley Electric Association, Healy, Alaska. https://doi.org/10.26616/NIOSHHETA9100472672 Burkhart, Joseph E. and Filios, Margaret S. "Health Hazard Evaluation Report: HETA 91–0047–2672: Golden Valley Electric Association, Healy, Alaska" (1998), https://doi.org/10.26616/NIOSHHETA9100472672 Burkhart, Joseph E. and Filios, Margaret S. "Health Hazard Evaluation Report: HETA 91–0047–2672: Golden Valley Electric Association, Healy, Alaska" , 1998, https://doi.org/10.26616/NIOSHHETA9100472672 Export RIS Citation Information.

:

Burkhart, Joseph E. ;

Filios, Margaret S.

1998/02/01 | Health Hazard Evaluation Reports (HHE)

:

In November 1990, the National Institute for Occupational Safety and Health (NIOSH) received a request for a Health Hazard Evaluation (HHE) from the p...
Health Hazard Evaluation Determination Report No. HE 78-131-586: Goodyear Tire and Rubber Company: Niagara Falls, New York

CITE Title : Health Hazard Evaluation Determination Report No. HE 78-131-586: Goodyear Tire and Rubber Company: Niagara Falls, New York Personal Author(s) : Stroman, Raymond E.;Taft, Richard M.; Corporate Authors(s) : National Institute for Occupational Safety and Health Published Date : 1979/04/01 Pages in Document : 13 pdf pages Series : Health Hazard Evaluation Reports (HHE) DOI : https://doi.org/10.26616/NIOSHHHE78131586 Stroman, Raymond E. and Taft, Richard M. (1979). Health Hazard Evaluation Determination Report No. HE 78-131-586: Goodyear Tire and Rubber Company: Niagara Falls, New York. https://doi.org/10.26616/NIOSHHHE78131586 Stroman, Raymond E. and Taft, Richard M. "Health Hazard Evaluation Determination Report No. HE 78-131-586: Goodyear Tire and Rubber Company: Niagara Falls, New York" (1979), https://doi.org/10.26616/NIOSHHHE78131586 Stroman, Raymond E. and Taft, Richard M. "Health Hazard Evaluation Determination Report No. HE 78-131-586: Goodyear Tire and Rubber Company: Niagara Falls, New York" , 1979, https://doi.org/10.26616/NIOSHHHE78131586 Export RIS Citation Information.

:

Stroman, Raymond E. ;

Taft, Richard M.

1979/04/01 | Health Hazard Evaluation Reports (HHE)

:

nvironmental sampling and medical evaluations were conducted at the Goodyear Tire and Rubber Company (SIC-3011), Niagara Falls, New York, on October 2...
Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers.

CITE Title : Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Corporate Authors(s) : National Institute for Occupational Safety and Health Published Date : 1989/02/01 Pages in Document : 1-46 URL : https://stacks.cdc.gov/view/cdc/180244 National Institute for Occupational Safety and Health (1989). Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers.. National Institute for Occupational Safety and Health "Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers." (1989) National Institute for Occupational Safety and Health "Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers." , 1989 Export RIS Citation Information.

:

National Institute for Occupational Safety and Health

1989/02/01 | National Institute for Occupational Safety and Health (NIOSH)

:

This publication was developed to serve as a guideline for health care workers and deals with methods for reducing the risk of becoming infected with ...
NIOSH skin notation (SK) profile : Morpholine [CAS No. 110-91-8]

CITE Title : NIOSH skin notation (SK) profile : Morpholine [CAS No. 110-91-8] Personal Author(s) : Hudson, Naomi;Dotson, G. Scott; Corporate Authors(s) : National Institute for Occupational Safety and Health Published Date : April 2017 Pages in Document : x, 9 numbered pages Series : NIOSH Numbered Publications URL : https://stacks.cdc.gov/view/cdc/45055 Hudson, Naomi and Dotson, G. Scott (2017). NIOSH skin notation (SK) profile : Morpholine [CAS No. 110-91-8]. Hudson, Naomi and Dotson, G. Scott "NIOSH skin notation (SK) profile : Morpholine [CAS No. 110-91-8]" (2017) Hudson, Naomi and Dotson, G. Scott "NIOSH skin notation (SK) profile : Morpholine [CAS No. 110-91-8]" , 2017 Export RIS Citation Information.

:

Hudson, Naomi ;

Dotson, G. Scott

April 2017 | NIOSH Numbered Publications

:

As the largest organ of the body, the skin performs multiple critical functions, such as serving as the primary barrier to the external environment. F...
Industrial hygiene survey report of BASF Corporation Coatings and Coolants Division, Anaheim, CA.

CITE Title : Industrial hygiene survey report of BASF Corporation Coatings and Coolants Division, Anaheim, CA. Personal Author(s) : Krishnan R;Piacitelli, Gregory M.;Votaw D; Published Date : 1989/02/24 Pages in Document : 1-17 URL : https://stacks.cdc.gov/view/cdc/180232 Krishnan R et al. (1989). Industrial hygiene survey report of BASF Corporation Coatings and Coolants Division, Anaheim, CA.. Krishnan R and Piacitelli, Gregory M. and Votaw D "Industrial hygiene survey report of BASF Corporation Coatings and Coolants Division, Anaheim, CA." (1989) Krishnan R et al. "Industrial hygiene survey report of BASF Corporation Coatings and Coolants Division, Anaheim, CA." , 1989 Export RIS Citation Information.

:

Krishnan R ;

Piacitelli, Gregory M.

1989/02/24 | National Institute for Occupational Safety and Health (NIOSH)

:

A visit to the BASF Corporation Coatings and Coolants Division (SIC- 2851), Anaheim, California was conducted as part of an effort to locate companies...